Riccardo De Giorgi

MD, DPhil, MRCPsych. Clinical Lecturer ST4-6 at University of Oxford, Department of Psychiatry

[Riccardo De Giorgi @rdegiorgi]

Psychedelics in mental healthcare show growing interest but uneven evidence https://t.co/dzlNMEM0YT

[Nicholas Fabiano, MD @NTFabiano]

Metabolic dysfunction is at the core of mental disorders.

Exercise, diet & sleep are fundamental to mental health.

Excited to serve as Guest Editor for this Topic Collection at BMJ Connections Mental Health.

[BMJ Mental Health @BMJMentalHealth]

🔔 BMJ Connections Mental Health is open for submissions!
A peer-reviewed, open access journal built on BMJ’s trusted standards of editorial rigour.
Learn about submitting today: https://t.co/3tCV8QuU3c
#OpenAccess

[BMJ Mental Health @BMJMentalHealth]

🚀 We have a new companion title: BMJ Connections Mental Health
An open access journal publishing the full spectrum of robust, reproducible, original research.

Get the first articles delivered to your inbox. Sign up here: https://t.co/bDaGzrBGFL
#OpenAccess

[BJPsych Journals @TheBJPsych]

JOURNAL CLUB INCOMING📢

The #BJPsych x @theCINP are discussing the paper "Academic psychiatry is everyone's business" w/c co-Chairs @angharaddecates @rdegiorgi @AsilaySeker

Register here: https://t.co/fmTAWY2tm7
Read the paper: https://t.co/4KFdfqwAwH

@CambUP_Psych @rcpsych

[Riccardo De Giorgi @rdegiorgi]

Join us on 29th Sept 2025 for a timely discussion on the "Future of Academic Psychiatry" with the #BJPsychJC and #CINP

Free registration for the live webinar: https://t.co/813DmS8cct
BJPsych paper "Academic Psychiatry is Everyone's Business": https://t.co/K5gQUO4CDK

[BMJ Mental Health @BMJMentalHealth]

Just launched: #BMJ Connections Mental Health, a new open access #journal from BMJ for #researchers, #clinicians & #funders advancing #global #mentalhealth
From #lab to #clinic, #realworld impact starts here.

@Rethink_ @NIMHgov
@mentalhealthuk
@APA @GPsych_BMJ
@psychiatry_ucam
@MedscapePsych
@rcpsych

👇🏼Read the editorial: https://t.co/u8eRvpzGiH
#MentalHealth #OpenAccess #BMJConnections

[Roger S. McIntyre, MD, FRCPC @rogersmcintyre]

I’ve been frequently asked by colleagues globally about the risk of suicidality associated with glucagon-like peptide-1 receptor agonists GLP-1 -RAs (eg semaglutide,tirzepatide) . This publication is a state of the union on the topic.

https://t.co/bXnddfYZiV

[Riccardo De Giorgi @rdegiorgi]

Congrats to a great research team Ana Ghenciulescu, Anna Pearse, Amedeo Minichino, Gaia Sampogna Andrea Fiorillo, who have made this study possible

[Riccardo De Giorgi @rdegiorgi]

Take a look at our new open-access paper “Transdiagnostic efficacy of lurasidone on depressive symptoms: systematic review and meta-analysis of randomised controlled trials” https://t.co/lPHpE6Mehq on @BJPsych!

[Riccardo De Giorgi @rdegiorgi]

📖 In summary, our findings suggest that lurasidone is a useful psychopharmacological tool for treating depressive symptoms in patients with severe mental illness, supporting the current evidence-base which has, to date, guided clinical recommendations based on expert opinion 📖

[No Context Brits @NoContextBrits]

Petition to make Matt Berry the next James Bond.

[Riccardo De Giorgi @rdegiorgi]

@Rational_Psych 🤣

[Riccardo De Giorgi @rdegiorgi]

@DrAmandaAdler Congrats @DrAmandaAdler! 🎉

[Riccardo De Giorgi @rdegiorgi]

🧠📱 Check out our new open-access paper: “A Survey of Preferences for Sensing Technologies in People with Severe Mental Illness in Acute Psychiatric Care” published in #AnnalsofBiomedicalEngineering

Read it at https://t.co/yQKWbooIAB

[Riccardo De Giorgi @rdegiorgi]

@DanielJDrucker @NatMetabolism Could you expand with your thoughts on this, please?

[Riccardo De Giorgi @rdegiorgi]

Delighted to feature in "The unexpected ways Ozempic-like drugs might fight dementia" https://t.co/xYEU0G6vyg via @NatGeo